Video: Kyphon and International Myeloma Foundation Partner to Raise Awareness of Multiple Myeloma Through National Education Pro
July 12 2007 - 8:00AM
PR Newswire (US)
'Myeloma Mobile' To Visit Kyphon's Sunnyvale Headquarters
SUNNYVALE, Calif., July 12 /PRNewswire/ -- Kyphon Inc.
(NASDAQ:KYPH) today announced its partnership with the
International Myeloma Foundation (IMF) to raise awareness about
multiple myeloma and the various treatment options available to the
more than 750,000 people worldwide afflicted with the disease. To
view the Multimedia News Release, go to:
http://www.prnewswire.com/mnr/kyphon/28925/ Myeloma is the second
most common blood cancer after lymphomas. Myeloma is a cancer of
the white blood cells and often results in the destruction of bone
tissue, resulting in painful fractures. Frequently, the first
symptoms of myeloma are pain in the lower back due to vertebral
compression fractures that occur in the absence of injury.
Approximately 55-70% of those with multiple myeloma suffer
vertebral compression fractures. Today, many new drug therapies
allow myeloma patients to maintain their daily lives for years and
decades. However, the painful fractures caused by myeloma can
significantly decrease the quality of life for myeloma patients.
Kyphon develops and markets devices used in balloon kyphoplasty, a
minimally invasive procedure for the treatment of spinal
compression fractures. The IMF's Myeloma Mobile, which Kyphon
sponsors to assist the IMF in raising awareness and educating
people across the United States and Canada about myeloma and the
need for increased support and resources for those touched by the
disease, will be visiting Kyphon's Sunnyvale headquarters from 1
p.m. to 2 p.m. PDT today, July 12, 2007. The Myeloma Mobile is the
brainchild of Michael Tuohy of Prospect, CT, who was diagnosed with
myeloma when he was just 36 years old. Michael is traveling with
his wife, Robin, and their two children around North America to
assist the IMF in its cause. Jeffrey Martinez, a 47-year-old from
San Jose, CA, is a myeloma patient who has benefited from balloon
kyphoplasty and will be at Kyphon to welcome the Myeloma Mobile.
"When I was diagnosed with myeloma, I was in so much back pain that
I had to use a walker to get around, and I couldn't bend over or
stand up for any period of time," said Martinez. "Within two weeks
of having seven vertebral compression fractures treated with
balloon kyphoplasty, I got rid of my walker and was completely off
my pain medication. Today, my life is pretty much back to normal."
"Kyphon is proud to be a sponsor of the Myeloma Mobile, which is
bringing nationwide attention to multiple myeloma," said Richard
Mott, president and chief executive officer of Kyphon. "Through our
work with spine specialists across the country, we have seen the
pain and suffering that myeloma patients endure as a result of
their disease. That is why we are working aggressively to improve
the quality of life of myeloma patients by increasing awareness of
and access to our balloon kyphoplasty procedure." Balloon
kyphoplasty is a minimally invasive procedure in which orthopaedic
balloons are used to gently elevate the fractured vertebra. The
procedure has been shown to achieve restoration of vertebral body
height and correction of spinal deformity. Additional benefits
include significant and sustained reduction in back pain,
significant and sustained improvement in quality of life and
ability to perform activities of daily living, and significant and
sustained improvement in mobility. Over 300,000 patients have been
treated to date with balloon kyphoplasty worldwide. Kyphon and the
IMF are partnering to educate patients, physicians and health care
professionals on the use of balloon kyphoplasty for vertebral
compression fractures. Through development of resources such as
education materials and sponsorship of patient and family seminars
in the United States, Kyphon and the IMF are helping to better
educate those touched by multiple myeloma. About Kyphon Kyphon
develops and markets medical devices designed to restore and
preserve spinal function and diagnose the source of low back pain
using minimally invasive technologies. The company's products are
used in balloon kyphoplasty for the treatment of spinal compression
fractures caused by osteoporosis or cancer, in the Functional
Anaesthetic Discography(TM) (F.A.D.(TM)) procedure for diagnosing
the source of low back pain, and in the Interspinous Process
Decompression (IPD(R)) procedure for treating lumbar spinal
stenosis. More information about the company and its products can
be found at http://www.kyphon.com/ and its patient education Web
site, http://www.spinalfracture.com/. Kyphon, KyphX and IPD are
registered trademarks, and Functional Anaesthetic Discography and
F.A.D. are trademarks, of Kyphon Inc. About the International
Myeloma Foundation The International Myeloma Foundation is the
oldest and largest myeloma organization, reaching more than 135,000
members in 113 countries worldwide. The IMF can be reached at (800)
452-CURE or http://www.myeloma.org/, and in Spanish at
http://www.myelomala.org/.
http://www.prnewswire.com/mnr/kyphon/28925DATASOURCE: Kyphon Inc.
CONTACT: Investors and Media, Julie D. Tracy, Vice President, Chief
Communications Officer of Kyphon Inc., +1-408-548-6687, Web site:
http://www.kyphon.com/
Copyright
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Jul 2023 to Jul 2024